ANAB

Anaptysbio, Inc

$63.42 -2.01 (-3.07%) At close · Jul 2

Market Cap

$1.85B

29,100,902

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel Faga	CEO	$706,011	—	$1,592,001	$3,345,653	$465,968	$24,310	$6,133,943
Paul Lizzul	—	$545,754	—	$505,703	$1,064,476	$221,031	$28,413	$2,365,377
Dennis Mulroy	CFO	$510,070	—	$397,444	$836,687	$224,431	$39,295	$2,007,927

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel Faga	CEO	$685,448	—	$6,889,127	$5,723,455	$308,452	$23,810	$13,630,292
Paul Lizzul	—	$529,859	—	$2,128,976	$1,741,973	$158,958	$23,742	$4,583,508
Dennis Mulroy	CFO	$495,213	—	$1,196,600	$1,368,672	$148,564	$29,858	$3,238,907

Key facts CIK 1370053 CUSIP 032724106 13F (30d) 4 filings 3 filers Visit website Investor relations